MAIDSTONE, U.K. - s4story -- Bedfont^® Scientific Limited, a world leader in breath analysis with nearly 50 years of expertise in the medical breath analysis industry, has formed a strategic partnership with Aerosol Medical Systems to improve Fractional exhaled Nitric Oxide (FeNO) testing accessibility in Latin America. Aerosol Medical Systems is an established leader in the field of respiratory therapy, providing a comprehensive service to improve quality of life.

"We are committed to diagnosing and treating respiratory diseases and have completed, in collaboration with Bedfont^®, the registration of the NObreath^® device with the healthcare authorities in Mexico." Comments Rodrigo León Molina, Director General and CEO at Aerosol Medical Systems. "The registration provides healthcare professionals with more accurate diagnostic tools and offers better treatment options for patients with asthma. This represents significant growth in the Mexican market, and will allow a larger number of tests to identify asthma early and better control the disease."

More on S For Story

• From the U.S. Marines to the Cosmos: Texas Veteran Elevates "Beyond Odyssey" Universe to Carry NASA's Spirit of Exploration Into Tomorrow
• TradingHabits.com Launches to Support Day Trader Well-being
• $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
• $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
• BITE Data raises $3m to build AI tools for global trade compliance teams

In 2019, a report found that in Mexico, 1,655 people died from asthma¹, highlighting the need for better asthma care across the region. The successful registration for the NObreath^® FeNO device in Mexico is a vital step to improving the accessibility of innovative diagnostic and management tools for asthma care.

"Our mission has always been to provide cutting-edge medical devices at affordable prices to improve accessibility and healthcare standards worldwide." Said Jason Smith, CEO at Bedfont^®. "By collaborating with Aerosol Medical Systems, we're helping clinicians across Mexico deliver faster, more personalised asthma care, empowering patients to live healthier lives."

Working on a foundation of shared values, including providing exceptional service, this partnership aims to improve asthma care in Mexico by ensuring that those living with this respiratory condition have access to instant, non-invasive, and simple breath testing to aid diagnosis and management.

More on S For Story

• Phinge Issues Notice of Possible Infringement, Investigates App-less AI Agents & Technology for Unauthorized Use of its Patented App-less Technologies
• Huntington Learning Center of Russellville Marks 1 Year Anniversary; Extends Reduced Grant-Aligned Rates to All Students in Learning Center Services
• CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress
• purelyIV Expands Wellness Services with Flu/COVID Testing and Menopause Coaching & Treatment
• George Simon Laso Releases New Book - The Art of Confusion

To learn more about the NObreath^®, visit the website here (https://www.nobreathfeno.com/).

References

1.Lopez-Bago A, Lascurain R, Hernandez-Carreño PE, Gallardo-Vera F, Argueta-Donohue J, Jimenez-Trejo F, et al. Sex, Age, and Regional Disparities in the Burden of Asthma in Mexico from 1990 to 2019: A Secondary Analysis of the Global Burden of Disease Study 2019. Sustainability [Internet]. 2023 Aug 20 [cited 2025 Oct 14];15(16):12599–9. Available from: https://www.mdpi.com/2071-1050/15/16/12599?